Michael Law joined CHSPR in 2009. Previously, he completed a Ph.D. in Health Policy from Harvard University and a M.Sc. from the London School of Economics and Political Science. He has also worked as a research associate at the University of Auckland in New Zealand and completed a post-doctoral fellowship at Harvard Medical School. Currently, he is appointed as an assistant professor in the School of Population and Public Health.
Michael’s research focuses on pharmaceutical policy. His work focuses on access to and use of prescription drugs, including studies of government drug coverage changes, the affordability of prescription drugs, generic drug pricing, the value of newer drugs, and the impact of direct-to-consumer advertising on drug use and costs. Currently, Michael is the primary investigator of two major CIHR-funded projects, including an evaluation of a BC policy that allows pharmacists to independently adapt and renew prescriptions. He is also currently investigating the structure and availability of private drug coverage.
His work has been published in leading medical journals and has received both Canadian and international media coverage. Since his appointment at UBC he has received several notable awards, including the 2011 Labelle Lectureship at McMaster University, the 2011-2012 CIHR Institute for Health Services and Policy Research Article of the Year award, a CIHR New Investigator Award, a Michael Smith Foundation for Health Research Scholar Award and an Early Career Scholar Award from the Peter Wall Institute for Advanced Studies.
Michael has student funding and is recruiting master’s and doctoral students interested in the following topics:
- Pharmaceutical policy evaluation
- The affordability of prescription drugs
- Pharmacist scope of practice and prescribing rights
- Private drug coverage
- Direct-to-consumer advertising